Site-Specific Incorporation of Selenocysteine by Genetic Encoding As a Photocaged Unnatural Amino Acid Adarshi Welegedara, Luke A
Total Page:16
File Type:pdf, Size:1020Kb
Subscriber access provided by AUSTRALIAN NATIONAL UNIV Article Site-specific incorporation of selenocysteine by genetic encoding as a photocaged unnatural amino acid Adarshi Welegedara, Luke A. Adams, Bim Graham, Thomas Huber, and Gottfried Otting Bioconjugate Chem., Just Accepted Manuscript • DOI: 10.1021/acs.bioconjchem.8b00254 • Publication Date (Web): 06 Jun 2018 Downloaded from http://pubs.acs.org on June 12, 2018 Just Accepted “Just Accepted” manuscripts have been peer-reviewed and accepted for publication. They are posted online prior to technical editing, formatting for publication and author proofing. The American Chemical Society provides “Just Accepted” as a service to the research community to expedite the dissemination of scientific material as soon as possible after acceptance. “Just Accepted” manuscripts appear in full in PDF format accompanied by an HTML abstract. “Just Accepted” manuscripts have been fully peer reviewed, but should not be considered the official version of record. They are citable by the Digital Object Identifier (DOI®). “Just Accepted” is an optional service offered to authors. Therefore, the “Just Accepted” Web site may not include all articles that will be published in the journal. After a manuscript is technically edited and formatted, it will be removed from the “Just Accepted” Web site and published as an ASAP article. Note that technical editing may introduce minor changes to the manuscript text and/or graphics which could affect content, and all legal disclaimers and ethical guidelines that apply to the journal pertain. ACS cannot be held responsible for errors or consequences arising from the use of information contained in these “Just Accepted” manuscripts. is published by the American Chemical Society. 1155 Sixteenth Street N.W., Washington, DC 20036 Published by American Chemical Society. Copyright © American Chemical Society. However, no copyright claim is made to original U.S. Government works, or works produced by employees of any Commonwealth realm Crown government in the course of their duties. Page 1 of 21 Bioconjugate Chemistry Site-specific incorporation of selenocysteine by genetic encoding as a photocaged unnatural amino 1 2 acid 3 4 5 1 2 1 2 1* 6 Adarshi P. Welegedara, Luke A. Adams, Thomas Huber, Bim Graham, Gottfried Otting 7 8 1 9 Research School of Chemistry, Australian National University, Canberra, ACT 2601, Australia 10 2 11 Monash Institute of Pharmaceutical Sciences, Monash University, Parkville, VIC 3052, Australia 12 13 14 *corresponding author 15 16 phone: +61 2 61256507 17 fax: +61 2 61250750 18 19 e-mail: [email protected] 20 21 22 23 ABSTRACT 24 Selenocysteine (Sec) is a naturally occurring amino acid that is also referred to as the 21st amino acid. 25 26 Site-specific incorporation of Sec into proteins is attractive, because the reactivity of a selenol group 27 28 exceeds that of a thiol group and thus allows site-specific protein modifications. It is incorporated into 29 30 proteins by an unusual enzymatic mechanism which, in E. coli and other organisms, involves the 31 recognition of a selenocysteine insertion sequence (SECIS) in the mRNA of the target protein. 32 33 Reengineering of the natural machinery for Sec incorporation at arbitrary sites independent of SECIS 34 35 elements, however, is challenging. Here we demonstrate an alternative route, whereby a photocaged 36 selenocysteine (PSc) is incorporated as an unnatural amino acid in response to an amber stop codon, 37 38 using a mutant Methanosarcina mazei pyrrolysyl-tRNA synthetase, Mm PCC2RS, and its cognate 39 40 tRNACUA. Following decaging by UV irradiation, proteins synthesized with PSc are readily tagged, e.g. 41 42 with NMR probes to study ligand binding by NMR spectroscopy. The approach provides a facile route 43 for genetically encoded Sec incorporation. It allows the production of pure selenoproteins and the Sec 44 45 residue enables site-specific covalent protein modification with reagents that would usually react first 46 47 with naturally occurring cysteine residues. The much greater reactivity of Sec residues allows their 48 selective alkylation in the presence of highly solvent-exposed cysteine residues. 49 50 51 52 53 54 55 56 57 58 59 60 ACS Paragon Plus Environment 1 Bioconjugate Chemistry Page 2 of 21 INTRODUCTION 1 2 3 Site-specific protein modification is a fundamental tool for a myriad of applications in protein 4 5 chemistry, including protein immobilization on surfaces, enhancement of protein solubility by 6 PEGylation, production of therapeutic conjugates with drugs, mimicking of natural post-translational 7 8 modifications, and introduction of tags for structural studies by fluorescence resonance energy transfer 9 10 (FRET), electron paramagnetic resonance (EPR) spectroscopy, or nuclear magnetic resonance (NMR) 11 spectroscopy.1−8 Cysteine is the most convenient target for protein modification as it is the most 12 13 nucleophilic and oxidation-sensitive among the 20 canonical amino acids. Thus site-directed 14 15 modifications of proteins are often carried out on cysteine residues with the formation of disulfide or 16 17 thioether bonds. To be site-selective, however, this approach requires that only a single cysteine residue 18 is amenable to the chemical reaction, which is difficult when the protein of interest contains other 19 20 cysteine residues that are essential for the structure or function of the protein. In principle, this problem 21 9 22 can be solved by genetic encoding of photocaged cysteine (PCC) as an unnatural amino acid (UAA), 23 24 which enables a protocol involving the chemical protection of the native cysteine residues, decaging of 25 the PCC residue and chemical modification and deprotection of the native cysteine residues.10 Charging 26 27 of the cognate amber suppressor tRNACUA with the PCC amino acid is elegantly achieved by a mutant 28 9 29 Methanosarcina barkeri pyrrolysyl-tRNA synthetase (Mb PylRS), named PCC2RS, but the number of 30 steps involved in selective cysteine labeling renders the overall process unattractive. A more 31 32 straightforward alternative is to incorporate a Sec residue, which is chemically more reactive than 33 34 cysteine, obviating the need for protection of any native cysteine residues. Sec is chemically similar to 35 11−13 36 cysteine but has a significantly lower pKa value (5.2 versus 8.5). This can be exploited for selective 37 modifications of Sec residues in the presence of native cysteine residues at slightly acidic pH values.14- 38 39 −17 A recent, very attractive application harnesses the exceptional reactivity of Sec residues for 40 17−19 41 expressed protein-ligation. 42 43 Site-specific incorporation of Sec is challenging. The natural mechanism employs a highly 44 specialized translation system, relying on a specific tRNA (tRNASec), selenophosphate synthase (SelD), 45 46 Sec synthase (SelA), a special EF-Tu-independent elongation factor (SelB), and a conserved mRNA 47 48 sequence (selenocysteine insertion sequence or SECIS) in the vicinity of the target UGA codon. The 49 requisite mRNA stem-loop structure comprised by the SECIS element restricts the sequence context 50 51 where Sec residues can be positioned.11,13 In an E. coli strain devoid of the release factor 1 (RF1), the 52 53 SECIS/SelB system has also successfully been harnessed for the synthesis of pure selenoproteins using 54 55 a UAG (amber) codon instead of the usual UGA codon but, in the absence of the SECIS element, this 56 approach results in full-length protein due to misincorporation of natural amino acids.20 Site-selective 57 58 Sec incorporation at an amber stop codon independent of SelB and the SECIS element has also been 59 60 ACS Paragon Plus Environment 2 Page 3 of 21 Bioconjugate Chemistry demonstrated, using a tRNASec engineered for EF-Tu–mediated Sec incorporation.21−24 At present, this 1 2 approach is limited to low yields of selenoproteins (<0.5 mg/L cell culture), and further optimization of 3 Sec 25 4 the engineered tRNA is difficult to conceive as it needs to be recognized both by SelA and EF-Tu. 5 Poor expression yields thus have prevented the use of this approach for subsequent applications that 6 7 require larger protein quantities, such as NMR spectroscopy or expressed protein ligation. The problem 8 9 of low yield is circumvented by a new system for EF-Tu mediated selenocysteine incorporation at 10 11 amber codons, which uses Aeromonas salmonicida selenocysteine synthase (SelA) to convert Ser-allo- 12 tRNA into Sec-allo-tRNA which is efficiently recognized by EF-Tu.26 The system can be used to obtain 13 14 selenoproteins in high yields, but it is prone to incorporation of serine in place of selenocysteine due to 15 16 incomplete conversion of Ser to Sec by SelA. This makes the strategy critically dependent on 17 18 optimization of the relative expression levels of allo-tRNA and SelA as well as the expression 26 19 temperatures, which are different for different proteins. 20 21 The wide interest in Sec incorporation has triggered the development of a range of alternative 22 23 strategies for the production of selenoproteins, in particular focusing on expression in E. coli, which is 24 the most readily used organism for protein production. In a straightforward way, cysteine residues can 25 26 globally be replaced by Sec by misloading the cysteinyl-tRNA with Sec in a growth medium 27 28 supplemented with Sec, but incorporation of cysteine cannot be completely avoided in this approach and 29 27 30 site-selectivity is achieved only if the native protein sequence contains only a single cysteine residue, 31 or a Sec-containing fragment is post-translationally ligated with a separately produced polypeptide.17 As 32 33 an alternative, it has been shown that a photocaged Sec, 4,5-dimethoxy-2-nitrobenzyl-Sec (DMNB-Sec), 34 35 can be incorporated as a UAA in yeast by genetic encoding based on an orthogonal LeuRS/tRNACUA 36 pair, with subsequent decaging providing a straightforward route to a site-specific Sec residue.16 This 37 38 system, however, requires high concentrations of DMNB-Sec (3 mM) to suppress erroneous 39 16 40 incorporation of leucine and isoleucine, and cannot be used in E.